4
Changes in Ownership
TScan Therapeutics, Inc. Filed Acc 0001193125-26-019729
Options or other derivatives
- Chief Financial Officer acquired 350,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Amello Jason Chief Financial Officer | 2026-01-20 | Grant or award · Stock Option (Right to Buy) | +350,000 | 350,000 | D: show line 1 in the form |
Loading xslF345X05/ownership.xml…